Lupin launches fixed dose triple combo inhaler for COPD in India

The product is an important addition to Lupin’s respiratory portfolio.
More news in Industry
IRDAI imposes ₹2 cr penalty on Star HealthJewellery demand remains resilient for Q3 despite gold price surge
U.S. FDA issues VAI classification to Natco Pharma’s FDF unit in Vizag